Xtant Medical Holdings (XTNT) Tops Q1 EPS by 1c, provides guidance

Xtant Medical Holdings (NYSE: XTNT) reported Q1 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $32.9 million versus the consensus estimate of $31.58 million.

GUIDANCE:

Xtant Medical Holdings sees FY2025 revenue of $127-131 million, versus the consensus of $128.3 million, representing growth of 8% to 12%, up from up prior guidance of $126 million to $130 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c